TRANSCODE THERAPEUTICS INC
(NASDAQ: RNAZ)

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.

0.461

+0.002 (+0.44%)
Range - - -   (-%)
Open -
Previous Close 0.459
Bid Price 5.860
Bid Volume 10
Ask Price 6.410
Ask Volume 10
Volume 66,040
Value -
Remark
Delayed prices. Updated at 23 Apr 2024 22:26.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis